Semax
Semax is a synthetic peptide derived from adrenocorticotropic hormone (ACTH) that has been extensively studied for its neuroprotective and cognitive-enhancing properties. Research indicates it may modulate brain-derived neurotrophic factor (BDNF) and protect neurons from hypoxic damage, making it a subject of interest in stroke recovery and cognitive decline.
01Dosing reference
02Mechanism of action
ACTH Receptor Modulation
Acts as an analogue of ACTH(4-10), binding to melanocortin receptors without hormonal activity.
BDNF and TrkB Upregulation
Increases the expression of Brain-Derived Neurotrophic Factor (BDNF) and its receptor TrkB in the hippocampus and forebrain.
Neuroprotection and Cognitive Enhancement
Enhances neuronal survival under stress, improves memory formation, and accelerates recovery from ischemic events.
03Human evidence
Improved recovery outcomes in acute ischemic stroke patients.
Clinical trials in Russia demonstrated that early administration of Semax significantly improved neurological recovery and reduced disability in stroke patients.
Enhanced cognitive performance and memory in healthy individuals under stress.
Studies on healthy volunteers showed improved attention and memory retention during highly demanding tasks.
04Preclinical evidence
Protection against hypoxic damage in neuronal cells.
In vitro and animal models showed increased cell survival and reduced apoptosis when exposed to low oxygen levels.
Stimulation of neurogenesis and synaptic plasticity.
Rodent studies demonstrated increased BDNF levels and enhanced synaptic connections in the hippocampus following Semax administration.
05What is known vs. unknown
- Derived from a fragment of adrenocorticotropic hormone (ACTH).
- Administered primarily via intranasal drops for direct brain access.
- Increases BDNF levels, supporting neuronal health and cognitive function.
- Has a long history of clinical use in Russia for stroke and cognitive disorders.
- Lack of large-scale, multi-center clinical trials outside of Eastern Europe.
- Long-term effects of continuous use in healthy individuals for cognitive enhancement remain under-researched.
06Safety & regulatory context
07Compared with Selank
08Appears in protocols
09Glossary
10Knowledge check
11Sources
More in Cognitive Enhancement
Selank
Selank is a synthetic heptapeptide analogue of the naturally occurring immunomodulatory peptide tuftsin. It has been extensively researched for its anxiolytic (anti-anxiety) and nootropic (cognitive-enhancing) properties, showing the ability to reduce stress and improve memory without the sedative side effects typical of traditional anti-anxiety medications.
Dihexa
Dihexa is an oligopeptide variant derived from angiotensin IV that binds to hepatocyte growth factor (HGF) and its receptor c-Met. Research in animal models suggests it has profound synaptogenic and neurogenic properties, showing potential for improving cognitive function and repairing brain damage in conditions like Alzheimer's disease and traumatic brain injury.
Nemifitide
Nemifitide (INN-00835) is a novel synthetic pentapeptide analog of melanocyte-inhibiting factor (MIF-1). Research indicates it may possess rapid-acting antidepressant properties, showing efficacy in clinical trials for major depressive disorder within days rather than weeks.